Skip to main content

Table 2 The postoperative rebleeding rates for patients who received preoperative Vit. K or FFP

From: Association of antithrombotic therapy with postoperative rebleeding in patients with cerebral amyloid angiopathy

 

Total

(N = 79)

vit.K

FFP

CAA

(n = 50)

vit.K

FFP

non-CAA

(n = 29)

vit.K

FFP

Antithrombotic therapy, No. (%)

30(38)

7(9)

9(11)

16 (32)

2(4)

3(6)

14 (48)

5(17)

6(21)

Postoperative rebleeding, No. (%)

14(18)

3(4)

5(6)

12(24)

2(4)

3(6)

2(7)

1(3)

2(7)

  1. CAA Cerebral amyloid angiopathy, vit.K Intravenous vitamin K, FFP Fresh Frozen Plasma